' 
![]()
SCIENTIFIC SCORE
Moderately Effective
Based on 4 Researches
8.5
USERS' SCORE
Good
Based on 3 Reviews
8.7
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
Saccharomyces boulardii(an S. cerevisiae Strain)
250 mg(5 Billion CFU)
†
MOS Yeast Fraction(Min. 35% Manno-oligosaccharides [MOS]) (S. cerevisiae)
200 mg
†
Top Medical Research Studies
9
S. boulardii reduces CDI risk
Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection.
Highly relevant for clinical practice
We examined whether Saccharomyces boulardii can help lower the risk of Clostridioides difficile infection (HO-CDI) in patients receiving antibiotics, particularly for pneumonia. Using a retrospective matched-cohort study, we compared patients on high-risk antibiotics who received S. boulardii to those who didn’t.
Our findings showed a significant 57% reduction in HO-CDI risk for pneumonia patients on S. boulardii, and a remarkable 76% reduction for those on ceftriaxone. This suggests that S. boulardii could be a valuable prophylaxis option in specific hospital settings.
Our findings showed a significant 57% reduction in HO-CDI risk for pneumonia patients on S. boulardii, and a remarkable 76% reduction for those on ceftriaxone. This suggests that S. boulardii could be a valuable prophylaxis option in specific hospital settings.
Read More
9
Probiotics reduce VAP incidence
A four-probiotic preparation for ventilator-associated pneumonia in multi-trauma patients: results of a randomized clinical trial.
High relevance for clinical practice
We assessed whether a specific probiotic regimen could help prevent ventilator-associated pneumonia (VAP) in multi-trauma patients who required long-term mechanical ventilation. In a randomized, controlled trial, patients received either a probiotic preparation—including Saccharomyces boulardii—or a placebo.
The results showed that probiotics significantly lowered VAP incidence from 28.3% to 11.9% and reduced sepsis rates alongside hospital stays. This suggests that probiotics, particularly when administered both enterally and topically, can effectively enhance recovery for critically ill patients.
The results showed that probiotics significantly lowered VAP incidence from 28.3% to 11.9% and reduced sepsis rates alongside hospital stays. This suggests that probiotics, particularly when administered both enterally and topically, can effectively enhance recovery for critically ill patients.
Read More
8
Saccharomyces boulardii improves pneumonia treatment
[Clinical effect of Saccharomyces boulardii powder combined with azithromycin sequential therapy in treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia].
Significant for pediatric treatment
We investigated how Saccharomyces boulardii, when paired with azithromycin, affects children suffering from diarrhea due to Mycoplasma pneumoniae pneumonia.
In our study, 88 children were split into two groups; one received standard treatment, while the other got Saccharomyces boulardii powder alongside their treatment. We compared both groups on various aspects including recovery time, hospital stay, and frequency of bowel movements.
The results showed that the combination therapy led to improved symptoms, shorter hospital stays, less frequent bowel issues, and better overall outcomes, without increasing the risk of side effects.
In our study, 88 children were split into two groups; one received standard treatment, while the other got Saccharomyces boulardii powder alongside their treatment. We compared both groups on various aspects including recovery time, hospital stay, and frequency of bowel movements.
The results showed that the combination therapy led to improved symptoms, shorter hospital stays, less frequent bowel issues, and better overall outcomes, without increasing the risk of side effects.
Read More
Most Useful Reviews
10
Intestinal recovery
I really like the product. My father fell ill with COVID-19 and developed pneumonia, requiring multiple antibiotics. His condition was severe, resulting in terrible diarrhoea. Upon the advice of an infectious disease doctor, he took acidophilus alongside Saccharomyces Boulardii. Within 10 days, his intestines fully recovered. I will definitely order more as there are no alternatives in pharmacies. HIGHLY RECOMMEND!!!!
Read More
9.5
Pathogen growth stopped
I ordered this drug on the advice of German doctors for my grandmother, who had a significant amount of Klebsiella pneumonia in her intestines. Though this bacterium is conditionally pathogenic, its growth can harm beneficial intestinal microflora and immunity. She took 2 capsules daily for 2 months between meals, and subsequent tests showed that the pathogen growth had ceased. The drug is helpful.
Read More
8.8
Balanced immune system
Great probiotic. After two bouts of pneumonia and numerous antibiotics, my system was a wreck. I tried other probiotics without the expected results, and my pulmo indicated my antibody levels were concerningly low, especially in terms of pneumonia risk. I needed to restore my immune system and decided to supplement with this product after researching its use in treating C-diff. Remarkably, it has balanced my body, and while I still experience some symptoms, they are much better managed now. Additionally, the price is excellent.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 4 Researches
8.5
9
S. boulardii reduces CDI risk
Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection.
Highly relevant for clinical practice
We examined whether Saccharomyces boulardii can help lower the risk of Clostridioides difficile infection (HO-CDI) in patients receiving antibiotics, particularly for pneumonia. Using a retrospective matched-cohort study, we compared patients on high-risk antibiotics who received S. boulardii to those who didn’t.
Our findings showed a significant 57% reduction in HO-CDI risk for pneumonia patients on S. boulardii, and a remarkable 76% reduction for those on ceftriaxone. This suggests that S. boulardii could be a valuable prophylaxis option in specific hospital settings.
Our findings showed a significant 57% reduction in HO-CDI risk for pneumonia patients on S. boulardii, and a remarkable 76% reduction for those on ceftriaxone. This suggests that S. boulardii could be a valuable prophylaxis option in specific hospital settings.
Read More
9
Probiotics reduce VAP incidence
A four-probiotic preparation for ventilator-associated pneumonia in multi-trauma patients: results of a randomized clinical trial.
High relevance for clinical practice
We assessed whether a specific probiotic regimen could help prevent ventilator-associated pneumonia (VAP) in multi-trauma patients who required long-term mechanical ventilation. In a randomized, controlled trial, patients received either a probiotic preparation—including Saccharomyces boulardii—or a placebo.
The results showed that probiotics significantly lowered VAP incidence from 28.3% to 11.9% and reduced sepsis rates alongside hospital stays. This suggests that probiotics, particularly when administered both enterally and topically, can effectively enhance recovery for critically ill patients.
The results showed that probiotics significantly lowered VAP incidence from 28.3% to 11.9% and reduced sepsis rates alongside hospital stays. This suggests that probiotics, particularly when administered both enterally and topically, can effectively enhance recovery for critically ill patients.
Read More
8
Saccharomyces boulardii improves pneumonia treatment
[Clinical effect of Saccharomyces boulardii powder combined with azithromycin sequential therapy in treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia].
Significant for pediatric treatment
We investigated how Saccharomyces boulardii, when paired with azithromycin, affects children suffering from diarrhea due to Mycoplasma pneumoniae pneumonia.
In our study, 88 children were split into two groups; one received standard treatment, while the other got Saccharomyces boulardii powder alongside their treatment. We compared both groups on various aspects including recovery time, hospital stay, and frequency of bowel movements.
The results showed that the combination therapy led to improved symptoms, shorter hospital stays, less frequent bowel issues, and better overall outcomes, without increasing the risk of side effects.
In our study, 88 children were split into two groups; one received standard treatment, while the other got Saccharomyces boulardii powder alongside their treatment. We compared both groups on various aspects including recovery time, hospital stay, and frequency of bowel movements.
The results showed that the combination therapy led to improved symptoms, shorter hospital stays, less frequent bowel issues, and better overall outcomes, without increasing the risk of side effects.
Read More
8
Probiotics reduced postoperative complications
A Four-Probiotics Regimen Reduces Postoperative Complications After Colorectal Surgery: A Randomized, Double-Blind, Placebo-Controlled Study.
High relevance for surgical outcomes
We looked into the effectiveness of a new four-probiotic formula during and after colorectal cancer surgery. In a double-blind, placebo-controlled study, patients were given either probiotics or a placebo before and after their procedures.
We found that those taking the probiotics had significantly fewer complications, including pneumonia and surgical site infections. Specifically, pneumonia rates dropped from 11.3% in the placebo group to just 2.4% in those receiving probiotics. This promising formulation may hold potential for improving recovery after surgery.
We found that those taking the probiotics had significantly fewer complications, including pneumonia and surgical site infections. Specifically, pneumonia rates dropped from 11.3% in the placebo group to just 2.4% in those receiving probiotics. This promising formulation may hold potential for improving recovery after surgery.
Read More
User Reviews
USERS' SCORE
Good
Based on 3 Reviews
8.7
10
Intestinal recovery
I really like the product. My father fell ill with COVID-19 and developed pneumonia, requiring multiple antibiotics. His condition was severe, resulting in terrible diarrhoea. Upon the advice of an infectious disease doctor, he took acidophilus alongside Saccharomyces Boulardii. Within 10 days, his intestines fully recovered. I will definitely order more as there are no alternatives in pharmacies. HIGHLY RECOMMEND!!!!
Read More
9.5
Pathogen growth stopped
I ordered this drug on the advice of German doctors for my grandmother, who had a significant amount of Klebsiella pneumonia in her intestines. Though this bacterium is conditionally pathogenic, its growth can harm beneficial intestinal microflora and immunity. She took 2 capsules daily for 2 months between meals, and subsequent tests showed that the pathogen growth had ceased. The drug is helpful.
Read More
8.8
Balanced immune system
Great probiotic. After two bouts of pneumonia and numerous antibiotics, my system was a wreck. I tried other probiotics without the expected results, and my pulmo indicated my antibody levels were concerningly low, especially in terms of pneumonia risk. I needed to restore my immune system and decided to supplement with this product after researching its use in treating C-diff. Remarkably, it has balanced my body, and while I still experience some symptoms, they are much better managed now. Additionally, the price is excellent.
Read More
